TechTalk XL: Cell & Gene Therapy

The TechTalk is a dynamic and engaging event that brings together professionals, researchers, and innovators from the life sciences and technology sectors. It provides a platform for knowledge exchange and collaboration.

What can you expect?
The TechTalk XL programme showcases speakers that highlight innovative breakthroughs across the theme Cell and Gene Therapy. By harnessing living cells and precisely targeting genetic information, cell and gene therapies are reshaping approaches to cancer, rare genetic disorders, and degenerative diseases.

NecstGen is pleased to host this edition of TechTalk XL. We invite you to join us for a focused afternoon of content and conversation on Cell & Gene Therapies.

Practical information
Date: Tuesday, June 30, 2026
Time: 15:30 – 18:30
Location: Mirai House, Sylviusweg 62, Leiden
Target audience: Professionals in the Life Science and Health Sector
Cost: Free

Sign up by following this link!

Programme
15:30 – Arrival & Registration
16:00 – Speaker Session
17:10 – Snapshot Talks
From 17:30 – Networking

Speakers
There will be an exciting speaker program, including the following experts from the field:

• Anneke Schuitemaker-Reurs – Mendus AB: Scaling up the production of vididencel, a cell-based immunotherapy; Developing active immunotherapy for myeloid blood cancers
• Nina Kotsopoulou – AAVantgarde Bio: AAVantgarde Bio’s journey for delivering large genes
• Wenliang Dong – ORCA Therapeutics: Turning Cold Tumors Hot for Durable Clinical Responses with ORCA-010, an Oncolytic Immunotherapy Platform
• Jordan Turnbull – Fuse Vectors: Beyond the cell: a new approach to AAV manufacturing
• Diederik Lokhorst – NecstGen: Development of a scalable, GMP-ready lentiviral vector manufacturing platform

Snapshot Talks

• Yuliya Shakalisava – EXIT071: Beyond the Cell: Harnessing Exosomes for Diagnostics and Therapeutics
• Tamar Tak – Leiden University Medical Center: Shared Resource Facilities for accelerating your research
• Emilie Viey – Quantoom Biosciences: An end-to-end RNA platform – from IVT to formulation – empowering faster, simpler, and scalable therapies production
• Thomas Denefle – Astraveus: Scaling Manufacturing, Not Facilities: A Novel Microfluidic Automated Cell Factory for High-Throughput CAR-T Manufacturing